Stockscreener 앱 받기
0.5399
1.87%
0.0099
시장 영업 전:
.55
0.0101
+1.87%
전일 마감가:
$0.53
열려 있는:
$0.532
하루 거래량:
13,162
Relative Volume:
0.11
시가총액:
$12.69M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.10%
1개월 성능:
-16.20%
6개월 성능:
-43.99%
1년 성능:
-51.36%
1일 변동 폭
$0.51
$0.5576
1주일 범위
$0.51
$0.5795
52주 변동 폭
$0.37
$2.76
Cellyan Biotechnology Co Ltd Stock (HKPD) Company Profile
Compare HKPD vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HKPD
Cellyan Biotechnology Co Ltd
|
0.5399 | 12.45M | 0 | 0 | 0 | 0.00 |
MCK
Mckesson Corp
|
754.40 | 92.09B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
270.78 | 53.49B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
200.37 | 47.00B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
73.90 | 8.45B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.60 | 1.31B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cellyan Biotechnology Co Ltd 주식(HKPD)의 최신 뉴스
Cellyan (HKPD) quarterly earnings report shows no revenue, EPS data available amid biotechnology sector headwinds.Shared Buy Zones - Newser
What net volume Cellyan (HKPD)? (Smart Money Outflows) 2026-04-29Buy Signals - newser.com
What leverage Cellyan (HKPD)? | HKPD Latest Quarter Earnings: Cellyan logs zero revenue, advances key drug pipeline progressSocial Trading Insights - newser.com
HKPD Latest Quarter Earnings: Cellyan logs zero revenue, advances key drug pipeline progressHot Market Picks - Newser
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
HKPD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cellyan (HKPD) Stock: Is It Ready for Entry (Institutional Demand) 2026-04-18Index Investing - Cổng thông tin điện tử tỉnh Lào Cai
HKPD Technical Analysis & ETF Price Forecast - Intellectia AI
[EFFECT] Cellyan Biotechnology Co., Ltd SEC Filing - Stock Titan
HKPD Stock Analysis: Cellyan Biotechnology Co. Ltd gains 1.59% to trade at 0.57 dollar - Newser
12 Industrials Stocks Moving In Monday's Intraday Session - Benzinga
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), the selling shareholders of Cellyan Biotechnology Co Ltd may sell up to 12.5 million Class A ordinary shares from time to time in the future. - Bitget
12.5M shares for resale — Cellyan Biotechnology (NASDAQ: HKPD) - stocktitan.net
Cellyan Biotechnology (HKPD) completes $6.5M private unit financing - Stock Titan
If You Invested $1,000 in Cellyan Biotechnology Co Ltd (HKPD) - Stock Titan
Cellyan Biotechnology Reports Lower Revenue and Profit in Latest Interim Results - TipRanks
Cellyan Biotechnology (HKPD) interim revenue and profit drop sharply in 2025 - Stock Titan
Cellyan Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended September 30, 2025 - marketscreener.com
HKPD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
12 Industrials Stocks Moving In Tuesday's After-Market Session - Benzinga
PETS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cellyan Biotechnology receives Nasdaq bid price deficiency notice - MSN
Cellyan Biotechnology boosts share capital and completes name change after December AGM - MSN
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency - The Manila Times
Cellyan Biotechnology receives Nasdaq minimum bid price deficiency notice - Investing.com
Cellyan Biotechnology Hit With Nasdaq Bid-Price Deficiency Notice, Shares Remain Listed - TipRanks
12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga
Cellyan Biotechnology Co Ltd (NASDAQ:HKPD) - intelligentinvestor.com.au
Cellyan Biotechnology Co Ltd (NASDAQ: HKPD)Share Price - intelligentinvestor.com.au
Clinical Trial Supplies Company Evaluation Report 2025: Market Led by Thermo Fisher Scientific, Sharp Services, and Parexel Through End-to-End Capabilities Span Packaging, Logistics, Trial ManagementResearchAndMarkets.com - FinancialContent
Cellyan Biotechnology Co., Ltd: Dividend historical data and projections - MarketScreener
HKPD: Static price chart | Cellyan Biotechnology Co., Ltd | KYG6365B1041 - MarketScreener
Cellyan Biotechnology Co., Ltd: Shareholders Board Members Managers and Company Profile | KYG6365B1041 - MarketScreener
There was once a stone that lay deep in the heart of a flowing river.Stock Buy Signals & Get The Analyst Consensus With One Click - bollywoodhelpline.com
Technical Charts Suggest Momentum Shift in Silicon Rental Solutions LimitedMoving Average Crossovers & Free Get High Impact Recommendations - bollywoodhelpline.com
Hawa Engineers Limited Nearing Breakout Level After BounceMid Cap Growth Trends & Plan Your Future With Strategic Investing - bollywoodhelpline.com
Is there any way to Buy Stocks in US market from IndiaTechnical Resistance Breaks & Outstanding Portfolio Tips - bollywoodhelpline.com
Robust Hotels Limited Included in Top Momentum ScanEarnings Call Summaries & These 3 Stocks Could Change Your Portfolio - bollywoodhelpline.com
🧠 Not a call – Just a neutral lens on structural context and how the market respects its own footprints.Stock Split Announcements & Maximum Profit Growth - bollywoodhelpline.com
Eastcoast Steel Limited Crosses 200 Day MA — Signal or NoiseEx-Dividend Date Alerts & Stay Ahead With Daily Market Discussions - bollywoodhelpline.com
Is This a Bottoming Phase for Bright Outdoor Media LimitedEarnings Call Summaries & Free Discover Fast Growing Stocks - bollywoodhelpline.com
Cellyan Biotechnology Boosts Share Capital and Completes Name Change After December AGM - TipRanks
Hong Kong Pharma Digital Technology Announces Board Changes - MSN
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Technical Analysis: Suraj Industries Ltd (890206)Long-Term Investment Plans & Superior Capital Growth - bollywoodhelpline.com
India Maritime Summit BeneficiariesTrading Volume Surges & AI Alerts You Can Actually Trust - bollywoodhelpline.com
RSI and MACD Indicate Shift in Osia Hyper Retail Limited SentimentMomentum Trading Signals & Big Profit Small Investment - bollywoodhelpline.com
South Indian paper mills (sipl)Stock Price Divergence & Master Stock Selection - bollywoodhelpline.com
Company LimitedMonthly Performance Summary & Free Trend Following Techniques - bollywoodhelpline.com
Macro Trends and Their Impact on HBL Engineering Limited (HBLENGINE)Bearish Engulfing Patterns & Start Investing With Free Smart Watchlists - bollywoodhelpline.com
The Andhra Sugars Limited (ANDHRSUGAR) Stock RalliesConsumer Goods Stocks & Superior Trading Strategies - bollywoodhelpline.com
Cellyan Biotechnology Co Ltd (HKPD) 재무 분석
Cellyan Biotechnology Co Ltd (HKPD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
4.00%
6.49%
자본화:
|
볼륨(24시간):